These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34538469)

  • 1. Cervical Total Disc Replacement: Food and Drug Administration-Approved Devices.
    Bydon M; Michalopoulos GD; Alvi MA; Goyal A; Abode-Iyamah K
    Neurosurg Clin N Am; 2021 Oct; 32(4):425-435. PubMed ID: 34538469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seven-year cost-effectiveness of ProDisc-C total disc replacement: results from investigational device exemption and post-approval studies.
    Radcliff K; Lerner J; Yang C; Bernard T; Zigler JE
    J Neurosurg Spine; 2016 May; 24(5):760-8. PubMed ID: 26824587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, randomized, multicenter study of cervical arthroplasty: 269 patients from the Kineflex|C artificial disc investigational device exemption study with a minimum 2-year follow-up: clinical article.
    Coric D; Nunley PD; Guyer RD; Musante D; Carmody CN; Gordon CR; Lauryssen C; Ohnmeiss DD; Boltes MO
    J Neurosurg Spine; 2011 Oct; 15(4):348-58. PubMed ID: 21699471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year clinical results of cervical total disc replacement compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled, multicenter investigational device exemption clinical trial.
    Radcliff K; Coric D; Albert T
    J Neurosurg Spine; 2016 Aug; 25(2):213-24. PubMed ID: 27015130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical Total Disc Replacement: Expanded Indications.
    Alves ÓL
    Neurosurg Clin N Am; 2021 Oct; 32(4):437-448. PubMed ID: 34538470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical arthroplasty versus anterior cervical fusion for symptomatic adjacent segment disease after anterior cervical fusion surgery: Review of treatment in 41 patients.
    Lee SB; Cho KS
    Clin Neurol Neurosurg; 2017 Nov; 162():59-66. PubMed ID: 28938108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of cervical total disc replacement vs fusion for the treatment of 2-level symptomatic degenerative disc disease.
    Ament JD; Yang Z; Nunley P; Stone MB; Kim KD
    JAMA Surg; 2014 Dec; 149(12):1231-9. PubMed ID: 25321869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Utility Analysis of the Cervical Artificial Disc vs Fusion for the Treatment of 2-Level Symptomatic Degenerative Disc Disease: 5-Year Follow-up.
    Ament JD; Yang Z; Nunley P; Stone MB; Lee D; Kim KD
    Neurosurgery; 2016 Jul; 79(1):135-45. PubMed ID: 26855020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, controlled clinical investigation comparing PCM cervical disc arthroplasty with anterior cervical discectomy and fusion. 2-year results from the US FDA IDE clinical trial.
    Phillips FM; Lee JY; Geisler FH; Cappuccino A; Chaput CD; DeVine JG; Reah C; Gilder KM; Howell KM; McAfee PC
    Spine (Phila Pa 1976); 2013 Jul; 38(15):E907-18. PubMed ID: 23591659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Surgical Interventions for Treating Multilevel Cervical Spondylotic Myelopathy via Anterior Approach: A Network Meta-Analysis.
    Li Z; Chen L; Li B; Wei J
    Pain Physician; 2019 Jul; 22(4):E275-E286. PubMed ID: 31337165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial: clinical article.
    Davis RJ; Kim KD; Hisey MS; Hoffman GA; Bae HW; Gaede SE; Rashbaum RF; Nunley PD; Peterson DL; Stokes JK
    J Neurosurg Spine; 2013 Nov; 19(5):532-45. PubMed ID: 24010901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Outcomes of the US FDA IDE Prospective, Randomized Controlled Clinical Trial Comparing PCM Cervical Disc Arthroplasty With Anterior Cervical Discectomy and Fusion.
    Phillips FM; Geisler FH; Gilder KM; Reah C; Howell KM; McAfee PC
    Spine (Phila Pa 1976); 2015 May; 40(10):674-83. PubMed ID: 25955086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical disc arthroplasty with the Prestige LP disc versus anterior cervical discectomy and fusion, at 2 levels: results of a prospective, multicenter randomized controlled clinical trial at 24 months.
    Gornet MF; Lanman TH; Burkus JK; Hodges SD; McConnell JR; Dryer RF; Copay AG; Nian H; Harrell FE
    J Neurosurg Spine; 2017 Jun; 26(6):653-667. PubMed ID: 28304237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and radiological outcome at 10 years of follow-up after total cervical disc replacement.
    Mehren C; Heider F; Siepe CJ; Zillner B; Kothe R; Korge A; Mayer HM
    Eur Spine J; 2017 Sep; 26(9):2441-2449. PubMed ID: 28676980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study.
    Zigler JE; Delamarter R; Murrey D; Spivak J; Janssen M
    Spine (Phila Pa 1976); 2013 Feb; 38(3):203-9. PubMed ID: 23080427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point of view: 5-year results of the FDA study.
    Zindrick MR; Spratt KF
    Spine (Phila Pa 1976); 2013 Feb; 38(3):210. PubMed ID: 23222647
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.
    Murrey D; Janssen M; Delamarter R; Goldstein J; Zigler J; Tay B; Darden B
    Spine J; 2009 Apr; 9(4):275-86. PubMed ID: 18774751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the three United States Food and Drug Administration investigational device exemption cervical arthroplasty trials.
    Upadhyaya CD; Wu JC; Trost G; Haid RW; Traynelis VC; Tay B; Coric D; Mummaneni PV
    J Neurosurg Spine; 2012 Mar; 16(3):216-28. PubMed ID: 22195608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical kinematics and radiological changes after Discover artificial disc replacement versus fusion.
    Hou Y; Liu Y; Yuan W; Wang X; Chen H; Yang L; Zhang Y
    Spine J; 2014 Jun; 14(6):867-77. PubMed ID: 24076441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study.
    Janssen ME; Zigler JE; Spivak JM; Delamarter RB; Darden BV; Kopjar B
    J Bone Joint Surg Am; 2015 Nov; 97(21):1738-47. PubMed ID: 26537161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.